219 related articles for article (PubMed ID: 33864025)
1. Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response.
Xue P; Hu X; Chang E; Wang L; Chen M; Wu TH; Lee DJ; Foster BL; Tseng HC; Ko CC
Exp Mol Med; 2021 Apr; 53(4):667-680. PubMed ID: 33864025
[TBL] [Abstract][Full Text] [Related]
2. Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget's disease of bone.
Hu X; Wong SW; Liang K; Wu TH; Wang S; Wang L; Liu J; Yamauchi M; Foster BL; Ting JP; Zhao B; Tseng HC; Ko CC
Sci Adv; 2023 Jan; 9(4):eade6998. PubMed ID: 36706179
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
4. Sargassum serratifolium attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and activation of the Nrf2/HO-1 signaling pathway.
Kim HJ; Park C; Kim GY; Park EK; Jeon YJ; Kim S; Hwang HJ; Choi YH
Biosci Trends; 2018; 12(3):257-265. PubMed ID: 30012915
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 knockout of MTA1 enhanced RANKL-induced osteoclastogenesis in RAW264.7 cells partly via increasing ROS activities.
Feng M; Liu L; Qu Z; Zhang B; Wang Y; Yan L; Kong L
J Cell Mol Med; 2023 Mar; 27(5):701-713. PubMed ID: 36786127
[TBL] [Abstract][Full Text] [Related]
6. CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
Xue P; Hu X; Powers J; Nay N; Chang E; Kwon J; Wong SW; Han L; Wu TH; Lee DJ; Tseng H; Ko CC
Biochem Biophys Res Commun; 2019 Apr; 511(3):637-643. PubMed ID: 30826055
[TBL] [Abstract][Full Text] [Related]
7. RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice.
Kanzaki H; Shinohara F; Itohiya K; Yamaguchi Y; Katsumata Y; Matsuzawa M; Fukaya S; Miyamoto Y; Wada S; Nakamura Y
FASEB J; 2017 Feb; 31(2):781-792. PubMed ID: 27836987
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.
Yamaguchi Y; Kanzaki H; Katsumata Y; Itohiya K; Fukaya S; Miyamoto Y; Narimiya T; Wada S; Nakamura Y
J Cell Mol Med; 2018 Feb; 22(2):1138-1147. PubMed ID: 29063666
[TBL] [Abstract][Full Text] [Related]
9. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.
Kanzaki H; Shinohara F; Kajiya M; Kodama T
J Biol Chem; 2013 Aug; 288(32):23009-20. PubMed ID: 23801334
[TBL] [Abstract][Full Text] [Related]
10. Isoquercitrin attenuates the osteoclast-mediated bone loss in rheumatoid arthritis via the Nrf2/ROS/NF-κB pathway.
Liu Y; Li TQ; Bai J; Liu WL; Wang ZR; Feng C; Pu LL; Wang XX; Liu H
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166977. PubMed ID: 38065271
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
[TBL] [Abstract][Full Text] [Related]
12. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's disease.
Wong SW; Huang BW; Hu X; Ho Kim E; Kolb JP; Padilla RJ; Xue P; Wang L; Oguin TH; Miguez PA; Tseng HC; Ko CC; Martinez J
Cell Death Differ; 2020 Jan; 27(1):71-84. PubMed ID: 31076632
[TBL] [Abstract][Full Text] [Related]
13. Urolithin A attenuates RANKL-induced osteoclastogenesis by co-regulating the p38 MAPK and Nrf2 signaling pathway.
Wei W; Peng C; Gu R; Yan X; Ye J; Xu Z; Sheng X; Huang G; Guo Y
Eur J Pharmacol; 2022 Apr; 921():174865. PubMed ID: 35231470
[TBL] [Abstract][Full Text] [Related]
14. Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget's Disease.
Obaid R; Wani SE; Azfer A; Hurd T; Jones R; Cohen P; Ralston SH; Albagha OME
Cell Rep; 2015 Nov; 13(6):1096-1102. PubMed ID: 26527009
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin Suppresses RANKL-Induced Osteoclastogenesis and Oxidative Stress Through Inhibiting NF-κB and MAPK and Activating AMPK/Nrf2.
Li Z; Chen C; Zhu X; Li Y; Yu R; Xu W
Calcif Tissue Int; 2018 Sep; 103(3):324-337. PubMed ID: 29721581
[TBL] [Abstract][Full Text] [Related]
16. Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells.
Liu M; Liu S; Zhang Q; Fang Y; Yu Y; Zhu L; Liu Y; Gong W; Zhao L; Qin L; Zhang Q
J Ethnopharmacol; 2021 Jul; 275():114129. PubMed ID: 33878416
[TBL] [Abstract][Full Text] [Related]
17. Icariin ameliorates osteoporosis in ovariectomized rats by targeting Cullin 3/Nrf2/OH pathway for osteoclast inhibition.
Si Y; Li Y; Gu K; Yin H; Ma Y
Biomed Pharmacother; 2024 Apr; 173():116422. PubMed ID: 38471268
[TBL] [Abstract][Full Text] [Related]
18. Regulator of G protein signaling 12 enhances osteoclastogenesis by suppressing Nrf2-dependent antioxidant proteins to promote the generation of reactive oxygen species.
Ng AYH; Li Z; Jones MM; Yang S; Li C; Fu C; Tu C; Oursler MJ; Qu J; Yang S
Elife; 2019 Sep; 8():. PubMed ID: 31490121
[TBL] [Abstract][Full Text] [Related]
19. NRF2 Is an Upstream Regulator of MYC-Mediated Osteoclastogenesis and Pathological Bone Erosion.
Park PSU; Mun SH; Zeng SL; Kim H; Bae S; Park-Min KH
Cells; 2020 Sep; 9(9):. PubMed ID: 32967239
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 differentially regulates osteoclast and osteoblast differentiation for bone homeostasis.
Wang L; Liang Y; Zhou X; Tian Y; Miao Z; Ko CC; Hu X
Biochem Biophys Res Commun; 2023 Sep; 674():19-26. PubMed ID: 37393640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
